Merck nears deal for flu-prevention biotech CidaraFinancial Times•Friday, November 14, 2025 at 12:07:43 AMNeutralFinancial MarketsSan Diego company’s lead drug is a potential alternative to vaccines for vulnerable patients— via World Pulse Now AI Editorial SystemRead OriginalWas this article worth reading? Share itSave this articleReport article